Qiagen (QGEN) Tops Q2 EPS by 1c; to Return $300M to Holders by End of 2017

Go back to Qiagen (QGEN) Tops Q2 EPS by 1c; to Return $300M to Holders by End of 2017

QIAGEN Reports Results for Second Quarter of 2016; Increased Commitment to Return $300 Million of Capital to Shareholders by End-2017

July 28, 2016 4:05 PM EDT

VENLO, The Netherlands, July 28, 2016 /PRNewswire/ --


 

Q2 2016 results show QIAGEN delivering on goals for acceleration during the year  Net sales of $334.4 million (+5% actual, +6% constant exchange rates, CER);
EPS of $0.09; adjusted EPS of $0.24 ($0.24 CER)  8% CER sales growth excluding impact from lower U.S. HPV test sales  Free cash flow up 75% to $77.6... More